ANTI-CLDN18.2 ANTIBODY CONJUGATES
Publication
EP4294441A1
Kind: A1
Mar 25, 2026
Applicants
Suzhou Transcenta Therapeutics Co., Ltd., Beijing Cancer Hospital
Inventors
QIAN, Xueming, ZHU, Hua, TENG, Fei, LI, Hongjun, YANG, Zhi, GU, Yi, DING, Jin, WANG, Feng
IPC Classifications
A61K 51/10 20060101AFI20260217BHEP
A61P 35/00 20060101ALI20260217BHEP
C07K 16/28 20060101ALI20260217BHEP
A61K 39/395 20060101ALI20260217BHEP
C07K 16/30 20060101ALI20260217BHEP
A61K 47/50 20170101ALI20260217BHEP
C12Q 1/6886 20180101ALI20260217BHEP
A61K 101/02 20060101ALI20260217BHEP
A61K 103/00 20060101ALI20260217BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR